Skip to main content
. 2016 Mar 18;95(11):e3134. doi: 10.1097/MD.0000000000003134

FIGURE 3.

FIGURE 3

Meta-analysis of included clinical trials with an analysis of the ORR of PD-1 and PD-L1 inhibitors among different dose groups in patients with advanced melanoma (fixed-effects model). (A) The comparison between the median-dose cohort and the low-dose cohort (RR = 1.37, P = 0.089); (B) the comparison between the median-dose cohort and the high-dose cohort (RR = 1.00, P = 0.990); (C) the comparison between the low-dose cohort and the high-dose cohort (RR = 1.32, P = 0.357).